Drug Profile
T4N5 liposome lotion
Alternative Names: Dimericine; Liposome encapsulated T4 endonuclease V; T4N5Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Applied Genetics Inc Dermatics
- Class Antineoplastics; Endodeoxyribonucleases; Skin disorder therapies
- Mechanism of Action DNA repair enzyme replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Skin cancer; Xeroderma pigmentosum
Most Recent Events
- 19 Aug 2009 Discontinued - Phase-II for Skin cancer in USA (Topical)
- 19 Aug 2009 Discontinued - Phase-III for Xeroderma pigmentosum in USA (Topical)
- 30 Aug 2007 T4N5 liposome lotion received Fast Track designation for Xeroderma pigmentosum in USA